This fall, parents and pediatricians will have a new option to protect babies from a lung-attacking virus that is the leading cause of hospitalization in infants under a year old in the United ...

Ohio State scientists engineered an antibody that may revolutionize prevention of the flu, other viruses and even non-viral diseases like cancer. The new molecule, delivered via nasal spray ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year of age from respiratory syncytial virus during their first RSV season ...